We've found
					11,964 Cardiology				
					clinical trials				
				
			
		
							
  	
	Heart Failure Clinical Trial
	Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure; With Decompensation Clinical Trial
	Heart Sounds Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure; With Decompensation Clinical Trial
	Heart Sounds Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure; With Decompensation Clinical Trial
	Heart Sounds Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure; With Decompensation Clinical Trial
	Heart Sounds Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Idiopathic Dilated Cardiomyopathy Clinical Trial
	DCM Precision Medicine Study
		Status: Enrolling
  
							
  	
	Idiopathic Dilated Cardiomyopathy Clinical Trial
	DCM Precision Medicine Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Paroxysmal Supraventricular Tachycardia (PSVT) Clinical Trial
	The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.
		Status: Enrolling,
							Phase
  
							
  	
	Paroxysmal Supraventricular Tachycardia (PSVT) Clinical Trial
	The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	FAST Therapy Trial of Fetal Tachyarrhythmia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	FAST Therapy Trial of Fetal Tachyarrhythmia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/14/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	FAST Therapy Trial of Fetal Tachyarrhythmia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	FAST Therapy Trial of Fetal Tachyarrhythmia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/14/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Rhythm Disorder Clinical Trial
	3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases Clinical Trial
	PRISM-GENOMICS-Smoking Cessation for Patients With Coronary Artery Disease Undergoing Cardiac Catheterization or Having a Heart Attack at Barnes Hospital in St. Louis Mo
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases Clinical Trial
	PRISM-GENOMICS-Smoking Cessation for Patients With Coronary Artery Disease Undergoing Cardiac Catheterization or Having a Heart Attack at Barnes Hospital in St. Louis Mo
		Status: Enrolling	
	
	
			Updated: 1/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Ventricular Tachycardia Clinical Trial
	Tachy Prediction Download Study
		Status: Enrolling,
							Phase
  
							
  	
	Ventricular Tachycardia Clinical Trial
	Tachy Prediction Download Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aortic Aneurysm, Abdominal Clinical Trial
	Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
		Status: Enrolling
  
							
  	
	Aortic Aneurysm, Abdominal Clinical Trial
	Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Disease Clinical Trial
	Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiac Disease Clinical Trial
	Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Disease Clinical Trial
	Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiac Disease Clinical Trial
	Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	PULsecath mechanicaL Support Evaluation
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	PULsecath mechanicaL Support Evaluation
		Status: Enrolling	
	
	
			Updated: 2/8/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Left Ventricular Dysfunction Clinical Trial
	Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling
  
							
  	
	Left Ventricular Dysfunction Clinical Trial
	Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Left Ventricular Dysfunction Clinical Trial
	Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling
  
							
  	
	Left Ventricular Dysfunction Clinical Trial
	Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Left Ventricular Dysfunction Clinical Trial
	Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling
  
							
  	
	Left Ventricular Dysfunction Clinical Trial
	Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Left Ventricular Dysfunction Clinical Trial
	Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling
  
							
  	
	Left Ventricular Dysfunction Clinical Trial
	Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Non-ST Elevation Myocardial Infarction (NSTEMI) Clinical Trial
	Comparison of Pharmacodynamic Effects of Tirofiban vs. Cangrelor in N-STEMI Patients Undergoing Percutaneous Coronary Intervention
		Status: Enrolling
  
							
  	
	Non-ST Elevation Myocardial Infarction (NSTEMI) Clinical Trial
	Comparison of Pharmacodynamic Effects of Tirofiban vs. Cangrelor in N-STEMI Patients Undergoing Percutaneous Coronary Intervention
		Status: Enrolling	
	
	
			Updated: 2/9/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Single Ventricle Heart Disease Clinical Trial
	Evaluation of Fontan-Associated Liver Disease
		Status: Enrolling,
							Phase
  
							
  	
	Single Ventricle Heart Disease Clinical Trial
	Evaluation of Fontan-Associated Liver Disease
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Post-Infarction Ventricular Septal Defect Clinical Trial
	The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Post-Infarction Ventricular Septal Defect Clinical Trial
	The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 5/1/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aortic Valve Stenosis Clinical Trial
	A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement
		Status: Enrolling
  
							
  	
	Aortic Valve Stenosis Clinical Trial
	A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Stroke Clinical Trial
	AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Paroxysmal Supraventricular Tachycardia Clinical Trial
	Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Paroxysmal Supraventricular Tachycardia Clinical Trial
	Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
We've found
					11,964 Cardiology
				
					clinical trials
				
				
				
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  	
	Heart Failure; With Decompensation Clinical Trial
	
Updated: 12/31/1969
  
  
  Heart Sounds Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure; With Decompensation Clinical Trial
	
Updated: 12/31/1969
  
  
  Heart Sounds Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Idiopathic Dilated Cardiomyopathy Clinical Trial
	
Updated: 12/31/1969
  
  
  DCM Precision Medicine Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Paroxysmal Supraventricular Tachycardia (PSVT) Clinical Trial
	
Updated: 12/31/1969
  
  
  The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/14/2017
  
  
  FAST Therapy Trial of Fetal Tachyarrhythmia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/14/2017
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/14/2017
  
  
  FAST Therapy Trial of Fetal Tachyarrhythmia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/14/2017
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Myocardial Ischemia and Transfusion
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases Clinical Trial
	
Updated: 1/2/2018
  
  
  PRISM-GENOMICS-Smoking Cessation for Patients With Coronary Artery Disease Undergoing Cardiac Catheterization or Having a Heart Attack at Barnes Hospital in St. Louis Mo
		Status: Enrolling	
	Updated: 1/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Ventricular Tachycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Tachy Prediction Download Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Aortic Aneurysm, Abdominal Clinical Trial
	
Updated: 12/31/1969
  
  
  Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Hemodynamic-GUIDEd Management of Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 2/8/2018
  
  
  PULsecath mechanicaL Support Evaluation
		Status: Enrolling	
	Updated: 2/8/2018
Click here to add this to my saved trials
	    
	 
  	
	Left Ventricular Dysfunction Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Left Ventricular Dysfunction Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Left Ventricular Dysfunction Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Left Ventricular Dysfunction Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Non-ST Elevation Myocardial Infarction (NSTEMI) Clinical Trial
	
Updated: 2/9/2018
  
  
  Comparison of Pharmacodynamic Effects of Tirofiban vs. Cangrelor in N-STEMI Patients Undergoing Percutaneous Coronary Intervention
		Status: Enrolling	
	Updated: 2/9/2018
Click here to add this to my saved trials
	    
	 
  	
	Single Ventricle Heart Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of Fontan-Associated Liver Disease
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Post-Infarction Ventricular Septal Defect Clinical Trial
	
Updated: 5/1/2018
  
  
  The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/1/2018
Click here to add this to my saved trials
	    
	 
  	
	Aortic Valve Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	